Showing 11,901 - 11,920 results of 29,412 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (nn decrease)) ))', query time: 1.00s Refine Results
  1. 11901

    Quantum Dot Hybridization of Piezoelectric Polymer Films for Non-Transfer Integration of Flexible Biomechanical Energy Harvesters by Haiyan Fu (133503)

    Published 2022
    “…Their specific output voltage and charge density were stably maintained at 7.16 V and 2.40 nC/cm<sup>2</sup>, which were 30.7 and 50.0% higher than those of FPENGs based on a pure piezoelectric polymer film, respectively. …”
  2. 11902

    Quantum Dot Hybridization of Piezoelectric Polymer Films for Non-Transfer Integration of Flexible Biomechanical Energy Harvesters by Haiyan Fu (133503)

    Published 2022
    “…Their specific output voltage and charge density were stably maintained at 7.16 V and 2.40 nC/cm<sup>2</sup>, which were 30.7 and 50.0% higher than those of FPENGs based on a pure piezoelectric polymer film, respectively. …”
  3. 11903

    Presentation_1_Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study.PPTX by Anthi Bouchla (9748362)

    Published 2022
    “…Surprisingly, patients’ RBC-iROS were decreased, a finding possibly related with the increased G6PDH levels in this group, suggesting a possible compensatory mechanism against the virus. …”
  4. 11904

    Supplementary Material for: GLPG2737, a CFTR Inhibitor, Prevents Cyst Growth in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease by figshare admin karger (2628495)

    Published 2025
    “…Results: GLPG2737 inhibited chloride flux in mIMCD-3 cells with an IC50 of 2.41 µM. In a 3D assay, GLPG2737 inhibited cyst growth in both wild-type (IC50 = 2.36 µM) and Pkd1 knockout (IC50 = 2.5 µM) mIMCD-3 cells. …”
  5. 11905

    <i>In Vitro</i> and <i>In Vivo</i> Antifungal Activity of Lichochalcone-A against <i>Candida albicans</i> Biofilms - Fig 5 by Dalia Seleem (2827508)

    Published 2016
    “…<i>albicans</i> enzymes secretion expressed in U/grams of dry weight after treatment with lichochalcone-A at concentrations of 625 μM and 1500 μM: <b>A.…”
  6. 11906
  7. 11907
  8. 11908
  9. 11909
  10. 11910
  11. 11911
  12. 11912
  13. 11913
  14. 11914
  15. 11915
  16. 11916

    Supplementary Material for: Vitamin D status and treatment in ESKD; links to improved CKD-MBD laboratory parameters in a real-world setting by Holden R.M. (3346661)

    Published 2024
    “…Laboratory parameters were measured every 6 (phosphate, calcium) or 12 weeks (25(OH)D3, PTH, ALP) until February, 2021. In September, 2018 a treatment algorithm of 50,000 IU weekly until sufficient, followed by 50,000 IU monthly was suggested. …”
  17. 11917

    Self-paced combined training alleviated oxidative stress, inflammatory responses and hyperlipidaemia in people living with multiple sclerosis: a randomised controlled trial by Sonda Jallouli (20484146)

    Published 2024
    “…</p> <p><b>Results:</b> Comparatively with CG, the TG showed a decrease in advanced oxidation protein products (p = 0.002, Hedges’g (g) = 1.50) and total thiols (p = 0.0011, g = 1.57), as well as an increase in reduced glutathione (p = 0.03, g = 0.98). …”
  18. 11918

    Items. by Samuel W. Terman (13584382)

    Published 2023
    “…<div><p>Epilepsy is a common, serious condition. Fortunately, seizure risk decreases with increasing seizure-free time on antiseizure medications (ASMs). …”
  19. 11919

    Survey feedback. by Samuel W. Terman (13584382)

    Published 2023
    “…<div><p>Epilepsy is a common, serious condition. Fortunately, seizure risk decreases with increasing seizure-free time on antiseizure medications (ASMs). …”
  20. 11920

    DataSheet_1_A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor ac... by Zhiyu Huang (638377)

    Published 2023
    “…Background<p>QL1604 is a humanized immunoglobulin G4 monoclonal antibody against programmed cell death protein 1. …”